Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Alcidion reports record 2026 and forecasts growth for 2027 — shares rise 8%

Alcidion recorded a 27% revenue increase in fiscal 2026 to AUD 51.6m, an ARR of AUD 38.3m (+34%) and a record total contract value of AUD 78.5m. The company generated positive operating cash flow (AUD 6.8m), finished the year debt-free with AUD 20.6m in cash and reported an adjusted EBITDA of AUD 6.8m. Shares rose about 8% after the results, as management expects both revenue and adjusted EBITDA in 2027 to exceed 2026 levels and already cites sold/renewed revenue of AUD 44.9m. Risks remain the timing of large contract wins, margin pressure on capital licences and competitive pressure in the UK. » More on de.investing.com
Alcidion achieves best Q1 in two years with $8.2m in new contracts

In Q1 2025 Alcidion reported its strongest performance in two years with $8.2m in new contracts. Operating cash outflow fell sharply from $4m to $600,000, the cash balance is $16.4m and the company is debt-free. Contracted revenue for 2026 stands at $36.3m, and Alcidion confirms guidance for positive EBITDA and operating cash flow. Management is examining market entries in Saudi Arabia and Canada for international expansion; the share last fell 1.05% to $0.094. » More on de.investing.com
Alcidion benefits from strong cash flow and order growth in Q4 2025

Alcidion recorded a record increase in new orders and positive operating cash flow in the fourth quarter of 2025, which drove the share price up by 12.5%. The company is well positioned for further growth with $17.7 million in liquidity and no debt, and expects EBITDA of over $4.5 million for fiscal year 2025. Risks include potential delays in implementations and challenges in expanding into new markets. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2022, ALCIDION GROUP LTD has already paid €0.0717 in dividends. The last payout was in July 2022.

Financials

In the last quarter, ALCIDION GROUP LTD had revenue of €15.85m and net profit of €578.38k

(EUR)	June 2026	YoY
Revenue	15.85m	-
Gross profit	2.46m	-
Net profit	578.38k	-
EBITDA	212.58k	-

Fundamentals

Metric	Value
Market capitalization	€87.52m
Number of shares	1.35bn
52-week high/low	€0.0895 - €0.0513
Dividends	No
Beta	1.02
P/E ratio	61.76
PEG ratio	1.48
P/B ratio	1.55
P/S ratio	2.74

Company profile

Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; and ExtraMed, a patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.